NR3C1

Clinical trials for NR3C1 explained in plain language.

Never miss a new study

Get alerted when new NR3C1 trials appear

Sign up with your email to follow new studies for NR3C1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Supercharged immune cells take on deadly brain tumors

Disease control Not yet recruiting

This early-phase trial tests a new way to treat glioblastoma that has come back after standard therapy. Doctors will deliver specially engineered natural killer (NK) cells directly into the brain to attack the tumor. The study includes 36 adults and aims to find the safest dose a…

Matched conditions: NR3C1

Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated May 13, 2026 16:00 UTC

NR3C1

Get alerted when new NR3C1 trials appear

Supercharged immune cells take on deadly brain tumors